Correction: Time-dependent diffusion MRI for noninvasive molecular subtype differentiation and biological correlation in breast cancer: emphasizing the emerging three-tier HER2 classification - Scorecard - MDSpire

Correction: Time-dependent diffusion MRI for noninvasive molecular subtype differentiation and biological correlation in breast cancer: emphasizing the emerging three-tier HER2 classification

  • By

  • Mingzhe Xu

  • Kuiyuan Liu

  • Shouning Zhang

  • Haotian Li

  • Renzhi Zhang

  • Chunmiao Xu

  • Junhui Yuan

  • Yue Wu

  • Dan Wu

  • Xuejun Chen

  • Jinrong Qu

  • June 9, 2026

  • 0 min

Share

Clinical Scorecard: Correction: Time-Dependent Diffusion MRI for Noninvasive Differentiation of Molecular Subtypes and Biological Associations in Breast Cancer: Highlighting the New Three-Tier HER2 Classification

At a Glance

CategoryDetail
ConditionBreast Cancer
Key MechanismsTime-dependent diffusion MRI for molecular subtype differentiation
Target PopulationPatients with breast cancer
Care SettingOncology

Key Highlights

  • Correction on funding statement for the study
  • Emphasis on three-tier HER2 classification
  • Noninvasive differentiation of molecular subtypes
  • Biological associations in breast cancer
  • Updated funding sources listed

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients with breast cancer undergoing MRI

          Focus on molecular subtype differentiation

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Time-dependent diffusion MRI for noninvasive molecular subtype differentiation and biological correlation in breast cancer: emphasizing the emerging three-tier HER2 classification

            • by Mingzhe Xu, Kuiyuan Liu, Shouning Zhang, Haotian Li, Renzhi Zhang, Chunmiao Xu, Junhui Yuan, Yue Wu, Dan Wu, Xuejun Chen, Jinrong Qu

            • June 9, 2026

            Related Content

            Splenic flexure colon cancer may represent a distinct prognostic subtype associated with elevated systemic inflammation and impaired nutritional status

            What the Biggest ASCO Cancer Research Updates Could Mean for Patients

            Each year, the American Society of Clinical Oncology Annual Meeting brings together cancer specialists from around the world to share the research most likely to shape the next chapter of cancer care. This year’s major updates point to several important themes: more precise treatment, smarter use of surgery and chemotherapy, new approaches for difficult-to-treat cancers and a growing recognition that supportive care, including exercise, can be part of cancer treatment planning.

            • by

            • June 8, 2026

            • 10 min
            TIFA: a signaling hub linking inflammation, innate immunity, and human disease